Active ingredient

Latanoprost 50 micrograms/ml.


Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension in adults (including elderly patients). Reduction of elevated IOP in pediatric patients with elevated IOP and pediatric glaucoma.


30 single-dose containers of 0.4 ml of eye drops in solution.


The recommended therapeutic dose is one drop in the affected eye(s) once a day. The optimal effect is obtained if latanoprost is administered at night. For single use only. Discard any unused solution immediately after use.

Summary of Product Characteristics (external link to the Spanish Drug Agency)